How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
With two cores at 240 MHz and about 8.5 MB of non-banked RAM if you’re using the right ESP32-S3 version, this MCU seems at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback